当前位置:首页 - 行情中心 - 科华生物(002022) - 财务分析 - 现金流量表

科华生物

(002022)

  

流通市值:34.92亿  总市值:34.92亿
流通股本:5.14亿   总股本:5.14亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金873,716,596.44414,395,641.312,074,536,262.261,465,233,149.53
  收到的税费返还582,838.46348,998.275,697,500.854,762,231.32
  收到其他与经营活动有关的现金31,080,860.913,362,362.6983,130,454.163,406,434.89
  经营活动现金流入小计905,380,295.8428,107,002.272,163,364,217.211,533,401,815.74
  购买商品、接受劳务支付的现金477,104,365.73223,814,645.441,224,140,126.69815,801,866.08
  支付给职工以及为职工支付的现金280,221,819.99157,413,514.31543,915,765.68430,376,679.36
  支付的各项税费30,728,130.118,530,639.5692,435,429.2769,957,471.06
  支付其他与经营活动有关的现金168,322,620.6979,640,184.75352,988,895.24287,027,993.44
  经营活动现金流出小计956,376,936.51479,398,984.062,213,480,216.881,603,164,009.94
  经营活动产生的现金流量净额-50,996,640.71-51,291,981.79-50,115,999.67-69,762,194.2
二、投资活动产生的现金流量:
  收回投资收到的现金--315,000,000165,000,000
  取得投资收益收到的现金950,951.51410,373.812,917,113.319,032,828.75
  处置固定资产、无形资产和其他长期资产收回的现金净额4,099,439.372,549,733.896,273,720.23,888,038.83
  处置子公司及其他营业单位收到的现金净额100,000---
  投资活动现金流入小计5,150,390.882,960,107.69334,190,833.51177,920,867.58
  购建固定资产、无形资产和其他长期资产支付的现金65,131,594.2232,066,928.81254,819,904.18180,865,362.54
  投资支付的现金--3,500,0001,750,000
  投资活动现金流出小计65,131,594.2232,066,928.81258,319,904.18182,615,362.54
  投资活动产生的现金流量净额-59,981,203.34-29,106,821.1275,870,929.33-4,694,494.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金--2,786,0952,786,095
  其中:子公司吸收少数股东投资收到的现金--2,786,0952,786,095
  取得借款收到的现金295,372,654.86110,663,735.31399,781,366.71118,075,216.96
  收到其他与筹资活动有关的现金--6,132,655.75500,000
  筹资活动现金流入小计295,372,654.86110,663,735.31408,700,117.46121,361,311.96
  偿还债务支付的现金172,555,251.8263,765,647.44871,542,039.95632,829,088.32
  分配股利、利润或偿付利息支付的现金54,741,780.0844,613,568.6269,842,043.7153,078,833.16
  其中:子公司支付给少数股东的股利、利润50,197,00042,849,00045,400,00030,400,000
  支付其他与筹资活动有关的现金5,721,059.421,879,360.45241,461,176.7399,966,528.22
  筹资活动现金流出小计233,018,091.32110,258,576.511,182,845,260.39785,874,449.7
  筹资活动产生的现金流量净额62,354,563.54405,158.8-774,145,142.93-664,513,137.74
四、汇率变动对现金及现金等价物的影响584,918.122,676,669.893,155,507.38-4,656,538.32
五、现金及现金等价物净增加额-48,038,362.39-77,316,974.22-745,234,705.89-743,626,365.22
  加:期初现金及现金等价物余额860,377,257.92864,626,234.891,605,611,963.811,605,614,434.34
  期末现金及现金等价物余额812,338,895.53787,309,260.67860,377,257.92861,988,069.12
补充资料:
  净利润-140,116,685.34--730,647,366.78-
  资产减值准备21,392,766.4-225,183,072.01-
  固定资产和投资性房地产折旧61,815,708.79-138,713,344-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧61,815,708.79-138,713,344-
  无形资产摊销32,137,203.58-82,431,117.44-
  长期待摊费用摊销6,778,662.34-12,851,391.51-
  处置固定资产、无形资产和其他长期资产的损失-2,344,755.76--4,208,562.56-
  固定资产报废损失352,271.69-3,342,366.79-
  公允价值变动损失19,103.55-1,172,720.33-
  财务费用5,930,458.53-41,369,106.13-
  投资损失-715,257.64--11,973,131.52-
  递延所得税-1,051,316.64--17,331,913.64-
  其中:递延所得税资产减少-504,950.21--7,585,820.58-
    递延所得税负债增加-546,366.43--9,746,093.06-
  存货的减少41,234,982.33--34,886,039.52-
  经营性应收项目的减少37,451,874.2-105,030,870.57-
  经营性应付项目的增加-137,559,322.84--80,236,692.38-
  现金的期末余额812,338,895.53-860,377,257.92-
  减:现金的期初余额860,377,257.92-1,605,611,963.81-
  现金及现金等价物的净增加额-48,038,362.39--745,234,705.89-
公告日期2025-08-272025-04-302025-04-282024-10-22
审计意见(境内)标准无保留意见
TOP↑